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Abstract
Background: Whilst pathways relating to the early stages of stroke care have become well established, strategies for
longer-term care are less developed and longer-term outcomes remain poor for many stroke survivors. New Start, a
complex intervention that includes needs identification, exploration of social networks and components of problem-
solving and self-management, was designed to improve stroke survivors’ quality of life by addressing unmet needs and
increasing participation. It is delivered approximately 6 months post-stroke by trained staff (facilitators). We are currently
undertaking a cluster randomised feasibility trial of the New Start intervention with an embedded process evaluation,
which is an important component of the design and testing of complex interventions as it provides an understanding
of how interventions are delivered and function in different settings.
Methods/design: This mixed methods process evaluation will explore the degree to which New Start is implemented
as intended, the impact of context on intervention delivery and the acceptability of the intervention for stroke survivors,
their families and practitioners. It will include non-participant observation of facilitator training and intervention delivery.
Interviews with stroke survivors, facilitators and other relevant staff (including administrators and managerial staff) will be
undertaken. Qualitative data from interview transcripts, facilitator reflections and observational field notes will be analysed
thematically alongside numerical data documenting intervention delivery collected as part of the trial.
Discussion: This process evaluation will identify factors that aid and impede implementation of the New Start
intervention and improve understanding of this novel approach to longer-term stroke care.
Trial registration: ISRCTN Registry, ISRCTN38920246. Registered on 22 June 2016.
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Background
The poor longer-term outcome for patients and their
carers after stroke has been well documented [1, 2]. We
are conducting a programme of research to develop an
evidence-based and replicable longer-term care strategy
for stroke survivors and their carers (the LoTS2Care
programme). Through a structured process, we have
developed an intervention, called New Start, that is
designed to improve stroke survivors’ quality of life by
addressing unmet needs and increasing participation.
The LoTS2Care feasibility trial is a cluster rando-
mised controlled trial (cRCT) of the New Start inter-
vention, designed to gather data to inform the
feasibility and acceptability of conducting a future
definitive cRCT.
New Start intervention
Our intent was to address the national guideline recom-
mendation for a 6-month review of health and social
care needs [3] with an evidence-based intervention. The
development of New Start will be reported separately,
but in summary, the intervention involves a trained facili-
tator eliciting a stroke survivor’s needs and mapping their
social networks at approximately 6 months post-stroke.
An open process seeks to enable stroke survivors to ad-
dress their identified needs and includes components of
problem-solving and self-management. The implementa-
tion of the intervention is supported by a training package
that trains individuals within a service unit to become
New Start facilitators.
Key intervention components
New Start training course Stroke services randomised
to the intervention arm will identify facilitators to be
trained in the intervention. It is anticipated that the New
Start facilitators will have experience in one of the
following roles: nurse, physiotherapist, occupational
therapist, health and well-being practitioner, or will have
other allied health professional training, and will have
stroke-specific knowledge or training.
The facilitators will be trained in delivering New Start
in the weeks preceding trial commencement. The initial
training will consist of a 2-day training course during
which facilitators will learn relevant theory about a
self-management approach and communication skills.
They will also learn about the intervention and how to
deliver it to stroke survivors, with the opportunity to ob-
serve aspects of the intervention being delivered and to
practise these skills. The facilitators will then practise
delivering the intervention in their services. A further
training day will take place approximately 3 to 6 weeks
after the initial course and will provide facilitators with
the opportunity to discuss progress and challenges with
colleagues in a supportive environment. Purposively
designed training records will be kept to document the
training received by each facilitator.
The New Start facilitators will be assessed for compe-
tency in the delivery of the New Start intervention ap-
proximately 16 weeks after completing the initial training
course, through a review of purposively designed docu-
ments to record intervention activity (termed activity re-
cords), reflective reports, interviews and observation. This
will coincide with trial recruitment commencing.
New Start supported self-management sessions with
stroke survivors The New Start intervention will be of-
fered to all stroke survivors within the stroke services allo-
cated to the intervention arm and who are approximately
6 months post-stroke. The New Start intervention consists
of an initial face-to-face meeting, at the stroke survivor’s
home or in clinic, with a trained facilitator. It seeks to help
stroke survivors identify any unmet needs they may have
and then to work with them to address these needs. A
leaflet providing a list of common problems faced by
stroke survivors (termed a priming tool) will be sent out
with an appointment letter in advance to highlight poten-
tial topics for discussion (unmet needs) and it invites the
survivor to add their own. At the meeting, these issues
and needs will be discussed (whether noted on the prim-
ing tool or not) and a supported self-management ap-
proach introduced. The process involves facilitated
action-planning, goal-setting, and review, all of which are
supported by New Start materials, a set of worksheets de-
veloped during previous phases of the LoTS2Care
programme. At each stage, participants are encouraged to
see those in their social network as resources to help in
this process. Booklets containing information about stroke
and useful contacts are also available and can be provided
to stroke survivors as appropriate. Stroke survivors can
have as many meetings with the facilitators as required. It
is anticipated that most stroke survivors will have at least
three visits and support may also be provided via other
means (e.g. by phone or email).
Feasibility trial
The protocol for the trial has been described in detail in
a separate paper [4]. Briefly, the trial involves randomisa-
tion of ten UK-based National Health Service (NHS)
stroke services on a 1:1 basis, either to implement the
New Start intervention in their service, with delivery to
the whole stroke population (intervention arm), or to
continue with usual care (control arm). Approximately
200 stroke survivors across all the stroke services will be
recruited into the trial. They will complete outcome as-
sessments at baseline, and three, 6 and 9 months
post-recruitment. In keeping with the cluster design, all
stroke survivors within the intervention arm services will
be offered the opportunity to receive the New Start
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intervention when they are 6 months post-stroke, inde-
pendent of their participation in the completion of out-
come measures as part of the trial.
This paper describes the protocol for the process
evaluation embedded within the LoTS2Care feasibility
trial, which has been designed in accordance with the
Medical Research Council guidance for conducting
process evaluations of complex interventions [5, 6].
Process evaluation development
The design for the process evaluation was developed
through an iterative process including:
 Further articulating the theoretical models of the
intervention and implementation
 Considering the relevant objectives for a process
evaluation in the context of this feasibility and cRCT
 Considering possible data sources and cross-referencing
with the objectives
 Developing a feasible protocol with consideration for
the available resource and compatibility with the
trial and implementation work.
A pragmatic approach was taken to ensure results
were applicable to the needs of this feasibility trial and
intervention development. We drew on principles of
evaluation frameworks (including realist evaluation [7, 8],
programme theory [9] and Grant’s framework [10]), a
taxonomy of factors that influence implementation (the
Consolidated Framework for Implementation Research
[11]) and a theory of the work done in implementation
(normalisation process theory, NPT [12]).
To articulate the theoretical model of the intervention
and its implementation further, two authors (NH and
TC) utilised the research findings from the prior inter-
vention development work, alongside discussions with
the research team exploring their understandings of the
intervention and their intended strategy for implementa-
tion. Following this, the logic of the developed intervention
was explicated in a diagram (Fig. 1) and accompanying
explanatory text.
In addition, an outcomes chain [9] was developed to
represent diagrammatically a theory of change, i.e. what
must be achieved in implementing the intervention to
bring about the overall outcome — improved quality of
life and increased participation for stroke survivors (Fig. 2).
CONTEXT: longer-term stroke care remains
under-developed; stroke generates
considerable health and social care costs.
EPIDEMIOLOGY: Stroke remains a major
cause of impairment in the UK; in the longer-
term, stroke survivors and their families face
a number of wider problems
New Start intervention logic model
PURPOSE: To improve QoL of community-dwelling stroke survivors through a
programme of facilitated self-management
RESOURCES
Stroke survivor
resources including
individual and social
resources such as
physical ability,
confidence, existing
support networks;
Facilitator-survivor
relationship;
Organisational
resources e.g. facilitator
training, identification of
population;
New Start materials
INTERVENTION
ACTIVITIES
Generating and
maintaining
understanding and a
positive relationship
between the facilitator
and survivor;
Active listening and
Socratic questioning;
Identifying unmet
needs;
Mapping existing social
support networks;
Survivor-directed (&
facilitator supported)
problem-solving
(process);
Prompting to action;
Supporting action;
Referrals to health and
social care
professionals
CONSEQUENTIAL
ACTIVITIES
Action taken by stroke
survivor to address
unmet needs;
Actions by supporters
Actions by health
professionals;
Reframing of
capabilities and
circumstances by stroke
survivor and/or
supporter
EFFECTS
Expressed unmet needs are addressed
(this may cover any domain, e.g.
health, specific activities, roles, etc.);
On behaviour:
Participation (engaging in meaningful
activity and with society) is enhanced;
On wellbeing:
Mental wellbeing is enhanced
(confidence, sense of agency,
independence & achievement, etc.);
Social wellbeing is enhanced
(satisfaction with relationships &
support);
Physical and environmental wellbeing
may be enhanced;
Positive affect increases;
On resources:
Social support networks are enhanced;
Individuals have the means (skills) to
solve future problems;
On society:
Survivor contributes more to society
Reduction of burden on NHS services
An outcomes chain
describes implementation
logic separately
Fig. 1 New Start intervention logic model. QoL quality of life
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Each box contains an outcome (of implementation)1 that
is related to other outcomes in the chain. Some of these
relationships are stronger than others. Some outcomes are
dependent2 on the outcome preceding it, for example, the
successful appointment of New Start facilitators is
dependent on funding being available. However, other
outcomes are not dependent on previous outcomes but
are importantly influenced by them, for example, facilita-
tors being capable and motivated to deliver New Start
may be more likely in the presence of management sup-
port. In all cases, achieving any given outcome does not
mean that the following outcome will be achieved. Rather,
it suggests that it can be (dependent relationship) or is
more likely to be (influential relationship).
A matrix to accompany the outcomes chain (an ex-
ample for one of the outcomes is provided in Table 1
for illustrative purposes) was also developed to de-
scribe details about success criteria for each outcome
and factors that may aid or impede its achievement [9].
The process evaluation described in this protocol will
be informed by these documents as a sensitising
framework for the project and will examine the utility
of the theory that underpins the design of the inter-
vention and its implementation [10].
Fig. 2 New Start outcomes chain. CCG Clinical Commissioning Group, QoL quality of life
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LoTS2Care is a feasibility randomised controlled trial.
A key component of feasibility is the implementation of
the intervention and therefore, much of this process
evaluation will focus on exploring the ways in which
New Start is implemented across the five intervention
sites. In terms of Grant’s framework, these are the
domains: delivery to clusters, response of clusters, re-
cruitment and reach of individuals, and delivery to in-
dividuals [10]. Data collection and analysis will focus
on exploring the outcomes contained in the blue boxes
in Fig. 2, because these are the outcomes directly asso-
ciated with implementation. This process evaluation
will, however, collect and access limited data from con-
trol sites to make some comparisons between each of
the sites in the trial. It will also look at the response of
individuals: the ways in which the New Start interven-
tion is received by the target population (stroke survi-
vors) and what they do as a result. These latter
activities will primarily inform the feasibility of data
collection methods for a process evaluation of a future
effectiveness trial.
Aims and objectives
Our primary aim is to gain an understanding of how
New Start is implemented and received by stroke survi-
vors in a range of settings to inform the optimisation of
its future design and evaluation. The objectives of this
process evaluation are to:
1. Assess implementation fidelity. This will involve
exploring whether the intervention was delivered to
stroke survivors with fidelity, but the focus will be
on assessing implementation processes and will be
informed by strategies within the Borelli framework
[13]. This framework provides guidelines and
strategies for assessing and monitoring treatment
fidelity across five domains: study design, provider
training, treatment delivery, treatment receipt and
treatment enactment.
2. Explore and clarify causal assumptions
regarding implementation. This will involve
looking at whether the activities and outcomes
proposed in the logic model (e.g. funding available,
New Start facilitator in post, and facilitators capable
and motivated to deliver the care strategy) operate
as intended, whether outcomes relate to one
another as anticipated and which outcomes in the
outcomes chain are necessary and which are
redundant. It will also involve identifying factors
that disrupt or facilitate activity or outcome
achievement. For example, do unspecified or
unanticipated activities contribute to outcome
achievement, or do any activities result in
unintended consequences?
3. Investigate the contextual factors associated
with variations in intermediate outcomes
between sites. This will involve a qualitative
exploration of which contextual factors affect the
implementation of the intervention in a site and
which contextual factors are affected by the
implementation of the intervention. It will also
involve exploring the usual care provided in
control sites.
4. Explore the views, perceptions and acceptability
of the intervention to facilitators, stroke
survivors and carers. This will involve exploring
facilitators’, stroke survivors’ and carers’ views of
the intervention and whether they find it useful
and acceptable.
5. Test and refine methods of data collection and
interrogation in preparation for a process
evaluation alongside a future effectiveness trial.
This will involve exploring whether we are able to
generate and access the data required for this work,
and whether the proposed methods are sufficient to
allow fidelity and impact to be assessed in a process
evaluation alongside a future effectiveness trial.
We also intend to identify specific elements of data
collection and interrogation that would optimise
the future process evaluation.
These objectives have guided the data collection and
data accessing processes. The process evaluation will,
however, remain sufficiently flexible to allow for emer-
gent questions to be addressed if necessary.
Methods/design
Data collection methods
Data collection will use a mixed methods approach,
combining interviews, non-participant observation, docu-
mentary analysis, numerical data documenting intervention
activity and data from public databases. The researchers
undertaking the process evaluation did not design New
Start nor will they be involved in implementation or trial
procedures.
Table 2 summarises the different types of data that will
be generated and used to address the process evaluation
objectives.
Data collected by the process evaluation researchers
Non-participant observation of intervention training
(addressing objectives 1, 2, 4 and 5) This will include
observing and recording the training delivered to facili-
tators and whether this was consistent with what was
intended by the LoTS2Care implementation team. It will
also include exploring the extent to which facilitators
engage with the training process and how they seek to
understand the intervention and their role in delivering
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it within their services. During the actual training ses-
sions, the process evaluation researchers will not par-
ticipate in any discussions or ask questions of the
facilitators. During suitable breaks between sessions,
however, the researchers may seek clarification or re-
quest further detail about something that has been ob-
served to understand better what has been seen. Data
generated through this observation will seek to ex-
plore the extent to which training was delivered as
intended, together with how the training was received
by facilitators. In addition to observation of training
sessions, the process evaluation researchers will also
look at the training records of each facilitator to gain a
picture of what training has occurred within each site.
They will record on standardised pro-formas what as-
pects of the training package each facilitator has
completed and when.
Self-report by facilitators (addressing objectives 1, 2,
4 and 5) Facilitators will be asked to complete the
Self-Efficacy and Performance in Self-management Sup-
port instrument (SEPSS) [14] prior to their training,
after both the initial training course and further training
day, and again at the end of the trial. The completed
forms will be analysed to gain an understanding of how fa-
cilitators view their capacity and current performance in
delivery of self-management support to stroke survivors.
Facilitators will also be asked to complete the NPT
toolkit [12, 15] during the early stages of implementation
and then every 3 months until the end of the trial. This
is an interactive online tool that can be used to help
people think through problems in the implementation of
an intervention. The toolkit is available from http://
www.normalizationprocess.org/npt-toolkit/ and requires
respondents to evaluate how the people and organisation
Table 2 Summary of data to be generated and used to address the process evaluation objectives
Objectives Data collection method Data generated
1. Assess implementation fidelity • Non-participant observation of intervention
training
• Self-report by facilitators
• Non-participant observation of intervention
delivery (including work shadowing)
• Interviews with facilitators and relevant site
staff
• Documentation of intervention activity
Field notes
Documents: structured reflective reports,
SEPSS forms and NPT toolkit reports
Documents: activity records. Transcripts.
2. Explore and clarify causal assumptions • Non-participant observation of intervention
training
• Self-report by facilitators
• Interviews with facilitators and relevant
site staff
Field notes
Documents: structured reflective reports,
SEPSS forms and NPT toolkit reports
Transcripts
3. Investigate the contextual factors associated
with variations in intermediate outcomes
between sites
• Site observation
• Interviews with facilitators and relevant
site staff
• Structured site surveys (including interviews)
• Documentation of intervention activity,
facilitator activity and usual care
• Data from public databases
Field notes
Documents: site surveys
Documents: activity records
Database records. Transcripts.
4. Explore the acceptability of the intervention
to facilitators, stroke survivors and carers
• Non-participant observation of intervention
training
• Self-report by facilitators
• Non-participant observation of intervention
delivery
• Interviews with stroke survivors and carers
• Interviews with facilitators
Field notes
Documents: structured reflective reports,
SEPSS forms and NPT toolkit reports
Transcripts
5. Test and refine methods of data collection
and interrogation in preparation for a process
evaluation alongside a future effectiveness trial
• Non-participant observation of intervention
training
• Self-report by facilitators
• Site observation
• Non-participant observation of intervention
delivery
• Interviews with stroke survivors and carers
• Interviews with facilitators and relevant site staff
• Structured site surveys (including interviews)
• Documentation of intervention activity, facilitator
activity and usual care
• Data from public databases
• Researcher reflective diary (including difficulties log)
Field notes
Documents: structured reflective reports,
SEPSS forms and NPT toolkit reports
Documents: site surveys
Documents: activity records
Database records
Documents: diary entries and logs. Transcripts.
NPT normalisation process theory, SEPSS Self-Efficacy and Performance in Self-management Support instrument
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involved in implementation are engaging in the work
(sense-making, cognitive participation, collective action
and reflexive monitoring). Upon completion, a report is
generated, which will be shared with the LoTS2Care im-
plementation team. The reports will be analysed to help
in understanding the perspectives of key personnel about
the implementation process.
As part of their ongoing training and development, facil-
itators will also be asked to participate in reflective prac-
tice. Facilitators will be asked to submit self-reflection
reports monthly, which will be supported by a reflective
framework created by the LoTS2Care implementation
team. The framework will provide guidance on what types
of questions the facilitators may consider, without becom-
ing overly prescriptive. These reflective reports will be
used to explore the implementation and delivery of the
intervention and the responses of facilitators to this work.
The reports may also provide helpful information about
the responses of the organisation and of those receiving
the intervention.
Site observation (addressing objectives 3 and 5)
There is a benefit in collecting naturally occurring data
when seeking to understand an environment or context
[16]. For this reason, prior to implementation of the
intervention, the process evaluation researchers will
undertake 1 day of non-participant observation within
each intervention site. These observations will increase
their understanding of what the organisational unit does,
how it does it and why, to inform their understanding of
usual care. This will enable the researchers to document
change. During the observations, researchers will not
seek to become involved in conversations, meetings or
interactions, so as not to influence local processes, but
may seek clarification about what has been observed
through conversation at an appropriate later time. In
addition to field notes, researchers will document what
kinds of services are provided and to whom, how people
are offered access to these services, what different roles
exist within each of the sites and why, and how decisions
are made within the organisation as a whole and on a
day-to-day basis.
Non-participant observation of intervention delivery
(addressing objectives 1, 4 and 5) We will observe the
intervention being delivered as it offers a direct view of
what each facilitator does, together with how the inter-
vention is received by stroke survivors and their sup-
porters [17–19]. Observation may include informal
conversation with the people observed to contextualise
and explain what has been observed, though such infor-
mal conversation will not occur during one-to-one in-
teractions between facilitators and stroke survivors/
carers. A purposively designed sensitising framework
(observation guide) will be used to guide field notes
taken during these observations.
Opportunity sampling will be employed to observe
intervention delivery. The intention is to observe at least
one face-to-face encounter for each facilitator during
both the establishing phase (between initial training and
facilitators being assessed as competent) and delivery
phase (between facilitators being assessed as competent
and the end of the trial). Each stroke survivor will have
their care observed only once. Because sampling is op-
portunistic, there are no inclusion or exclusion criteria
for stroke survivors and carers taking part in observed
sessions.
Alongside observation of the intervention delivery, a
process evaluation researcher will accompany a facilita-
tor during their day to gain insight into their working
patterns, the ways in which they interact with other col-
leagues in the stroke service, and the administrative
tasks and other duties that they do around intervention
delivery. During the work shadowing, the process
evaluator will capture data by taking field notes. The
data collected during work shadowing will be used to
tailor semi-structured interview guides for each of the
facilitators.
Interviews with stroke survivors (addressing objectives
4 and 5) Within the intervention sites, we will undertake
semi-structured interviews with stroke survivors and
their carers and supporters (where present and willing to
participate). These interviews will explore their experi-
ences of participating in the New Start intervention. Re-
searchers may also, with agreement, retrospectively
review and discuss intervention materials given to stroke
survivors and carers to understand their use in practice.
A topic guide will be devised drawing on our previous
intervention development and piloting work. Interviews
will aim to capture what stroke survivors and carers did
during the meetings with facilitators (i.e. how many
meetings there were, the duration of these meetings, and
what actions occurred during the meetings); what stroke
survivors and/or carers did as a result of participating in
the intervention; whether, how and to what extent the
intervention impacted the lives of stroke survivors and/
or carers; alongside their experiences of participating in
the intervention as a whole, including their experience
of, and perspective about, the facilitators.
Stroke survivors will be purposively sampled to
achieve a diversity of informants with respect to the ex-
tent of intervention activity and the time since first ac-
tivity using data from the activity records. Inclusion
criteria for participation in the interviews are: individuals
must have had (or be caring for someone who has had)
a stroke, they must be living in the community and
they must have been approached to take part in the
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New Start intervention. Only stroke survivors who are not
participating in the trial will be approached for interview
to avoid the effects of interviews and intervention delivery
being confounded. Approximately 25 stroke survivors and
their carers or supporters—approximately five from each
of the active sites—will be interviewed.
Following appropriate informed consent procedures,
stroke survivors and their carers or supporters will be
given the option of being interviewed together or separ-
ately. We expect that individuals will be interviewed only
once. To include stroke survivors who have varying de-
grees of ability to communicate, steps will be taken to
adapt the interview methods, for instance by using pic-
tures, adapting the topic guide or writing down key
words. Photographs of the facilitator(s) may also be
shown to stroke survivors to aid their memory of the
intervention where appropriate. These interviews will be
conducted in a quiet, private area (usually the stroke
survivor’s own home) and, with participants’ permission,
be audio recorded. Demographic data including partici-
pants’ age group, gender, ethnicity, living arrangements
and the relationship between the stroke survivor and
carer (where participating) will be collected from each
participant at the time of the interview for sample
characterisation.
Interviews with New Start facilitators and relevant
site staff (addressing objectives 1, 2, 3, 4 and 5) At
the end of the intervention implementation period, follow-
ing appropriate informed consent procedures, we will
conduct semi-structured interviews with all of the facilita-
tors and with any additional site staff involved in imple-
mentation of the intervention (including administrators
and managerial staff ). Semi-structured topic guides will be
utilised but will be sufficiently flexible to allow respon-
dents to introduce any issues they consider relevant. The
researchers will have gathered data from and about the
services throughout the trial, so the topic guide will be de-
vised close to when the interviews are undertaken, so that
it can be tailored to each individual and reflect the context
within which they work. Nonetheless, there will be core
questions that each person will be asked, and these will be
informed by previous work and the literature [20, 21].
Questions are likely to explore facilitators’ experiences of
the training package and whether they felt adequately pre-
pared to deliver the care strategy; their experiences of de-
livering the care strategy; the impact of the organisational
context on how the strategy has been implemented and
delivered (e.g. the development of the intervention in their
service, links with other staff members, organisations and
departments, and the flow of survivors through the ser-
vice); and their insights into the impact the care strategy
has had on their own practice, the organisation and for re-
cipients. These individual interviews will be conducted in
a quiet, private area—likely to be at the individual’s place
of work—and, with participants’ permission, be audio re-
corded. Demographic data including participants’ age
group, gender and professional background will be col-
lected at the time of interview for sample characterisation.
Additional data
Structured site surveys (addressing objectives 3 and 5)
As part of the feasibility trial, details of current service
provision will be collected by structured service surveys
to enable usual care and the wider context of the service
to be described. This survey will be repeated by post or
through interviews and site visits at further time points
throughout the trial to ensure any service and staffing
changes are captured.
Documentation of intervention activity, facilitator
activity and usual care (addressing objectives 1, 3
and 5) As part of the feasibility trial, structured activity
records will be used to capture specific information
about New Start activities delivered to stroke survivors
(including associated administrative and logistical work),
other work that facilitators do (such as team meetings and
training), and usual care provided by the service. Data in-
cludes time of occurrence, duration, specific activities con-
ducted and who was involved. This information will be
incorporated into assessments of intervention fidelity.
Data from public databases (addressing objectives 3
and 5) Data from national sources of anonymous data,
such as the Sentinel Stroke National Audit Programme,
Clinical Commissioning Group Outcomes Indicator Set
and census data provided by the UK Data Service, will be
accessed and incorporated to describe and contextualise
the services.
Researcher reflective diary (addressing objective 5)
Throughout the data collection period, the process
evaluation researchers will keep a reflective diary to
document their experiences of collecting data and will
report any specific difficulties on a log. These will be
analysed to explore whether the proposed methods of
collecting data are sufficient to allow fidelity and impact
to be assessed.
Analysis
Recorded interviews will be transcribed verbatim and
anonymised, and managed alongside anonymised obser-
vational field notes and records, facilitators’ reflective re-
ports and site surveys using the qualitative data analysis
tool QSR NVivo (version 10.0). Familiarisation with the
data will be followed by data reduction, during which
the researcher will engage in ‘selecting, focusing, simpli-
fying, abstracting, and transforming the data’ [22] to
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identify patterns and themes within and between sets of
data, thereby making sense of them and generating de-
scriptions and explanations relevant to the phenomena
being explored.
Standard approaches to demonstrating trustworthiness
and quality in qualitative research will be used, including
clearly documenting the research process (methods,
analysis and any problems encountered and solutions
found), transparently developing interview topic guides
in light of ongoing analysis, documenting the contextual
features in which the research was carried out, exploring
deviant cases and alternative explanations, and discuss-
ing emerging findings among the process evaluation
team. Moreover, the researchers will keep a reflexive
diary [19, 22–24].
Data from the activity records will be entered into a
database. These data will be analysed with descriptive
statistics such as count, proportion, mean, median,
standard deviation and interquartile range for each site
and facilitator, and represented in graphs as appropriate.
Ethical considerations
Written informed consent will be obtained from all
study participants. For stroke survivors who lack cap-
acity to give consent (e.g. due to cognitive difficulties as-
sociated with their stroke), consultee declaration will be
sought from someone who is well placed to make a judge-
ment on the stroke survivor’s wishes. The consultee will
be advised to set aside their own views and provide advice
on the stroke survivor’s participation in the research,
taking into consideration the person’s wishes and interests.
An information sheet advising them on their potential
role and their right to refuse will be provided. Capacity
to provide consent will be assessed by the researcher
during the conversation with each potential participant
before consultee declaration or consent is obtained.
The research team has previous experience of working
with and interviewing people who lack capacity and
who have cognitive impairments. For those who are un-
able to read or sign the consent form due to impair-
ments, but who have capacity to consent, the consent
procedure will be witnessed (the witness may be the
caregiver or significant other).
When seeking consent to observe intervention delivery,
if there are several people present (e.g. the stroke survivor
and a relative) and some decline consent while some pro-
vide consent, the researcher will seek to understand their
reasons for declining and obtain agreement for one of the
following options: no observation is conducted, the obser-
vation is conducted but nothing about those declining
consent is recorded, or the observation is conducted and
the people who declined consent are not present. The re-
searcher will be led by the will and needs of the survivor
and carer and will not seek to impose observation on
anyone who is unwilling. We believe this will provide
the appropriate balance between an individual’s right to
participate in the research and another’s right to refuse
participation.
The right of potential participants to refuse consent
without giving reasons will be respected at every stage of
the research process. All data will be kept confidential
and stored securely.
Safeguarding of Adults
It is possible that, during discussions, stroke survivors
may disclose information to the researcher, or the re-
searcher may have concerns, that the individual may
be experiencing abuse or is at risk of abuse. In such
circumstances, the researcher will follow the relevant
NHS Trust’s safeguarding adults policy (or equivalent
document).
Discussion
The process evaluation described here has been designed
to explore the degree to which New Start, a newly devel-
oped component of a longer-term stroke care strategy, is
implemented as intended, the impact of context on inter-
vention delivery and the acceptability of the intervention
for stroke survivors, their families and practitioners.
Process evaluation is recommended and regarded as good
practice in trials of complex interventions such as this,
which involve several interacting components, including
some element of behaviour change [10, 25]. Such evalua-
tions enable us to open the black box of complex inter-
ventions, providing insight into how interventions are
delivered on the ground and the underlying processes
influencing them [10].
There is little guidance for process evaluations in the
context of feasibility trials and relatively few published
examples. We have incorporated several highly struc-
tured data collection elements and have also included
less structured elements, such as field notes from obser-
vations and semi-structured interviews with a range of
stakeholders, to help us identify the most appropriate
factors to evaluate in a process evaluation alongside a
future effectiveness trial.
Our process evaluation has been designed to focus
on answering clear questions around implementation
fidelity, contextual factors, feasibility of data collection,
intervention acceptability and causal assumptions
based on a pre-specified theory of change and logic
model. The findings from this in-depth evaluation will
be invaluable in the interpretation of outcomes from
the feasibility cRCT and will inform the future opti-
misation of the New Start intervention and its defini-
tive evaluation.
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Endnotes
1In this sense, an outcome is any positive state that
should be achieved as part of the implementation and
can include the results of work done or a structure being
in place (an outcome of implementation), rather than
specifically a clinical or health outcome. The term out-
come is used in the wider evaluation field to emphasise
the focus of a theory of change (what the results or out-
comes of the change should be) rather than a theory of ac-
tion (what should be done to bring about the change).
2In a different context, one outcome may not be
dependent on the outcomes presented here. However, in
this context the dependent relationships proposed here
are the expected ways in which outcomes will be achieved,
given the other outcomes specified alongside them.
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